World Investment Advisors Acquires 13,007 Shares of Colgate-Palmolive Company $CL

World Investment Advisors raised its position in Colgate-Palmolive Company (NYSE:CL) by 102.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 25,704 shares of the company’s stock after acquiring an additional 13,007 shares during the period. World Investment Advisors’ holdings in Colgate-Palmolive were worth $2,031,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in CL. Brighton Jones LLC raised its stake in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP raised its stake in shares of Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after purchasing an additional 20,062 shares during the period. Schnieders Capital Management LLC. raised its stake in shares of Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after purchasing an additional 245 shares during the period. Nebula Research & Development LLC raised its stake in shares of Colgate-Palmolive by 165.5% during the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock valued at $939,000 after purchasing an additional 6,437 shares during the period. Finally, Sei Investments Co. raised its stake in shares of Colgate-Palmolive by 21.7% during the 2nd quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock valued at $59,732,000 after purchasing an additional 116,968 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Key Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Recent commentary says Colgate’s innovation strategy is helping drive market share gains, supported by premium product launches, pricing, and science-based offerings across oral care and pet nutrition. Why Colgate’s Innovation Strategy Is Fueling Market Share Gains
• Positive Sentiment: Morgan Stanley reportedly raised its price target on Colgate-Palmolive to $100 from $95 while keeping an Overweight rating, suggesting Wall Street still sees upside in the shares. Colgate-Palmolive (CL): The Best Stock to Buy in Falling Markets According to Wall Street Analysts
• Neutral Sentiment: Zacks Research modestly lowered its FY2028 EPS estimate to $4.39 from $4.44, a small trim that does not materially change the long-term outlook.
• Neutral Sentiment: The firm also made minor downward adjustments to FY2027, Q1 2028, Q4 2027, Q2 2027, Q1 2027, Q4 2026, Q3 2026, and Q2 2026 earnings estimates, which mainly reinforces a slightly softer earnings trajectory.
• Negative Sentiment: Multiple Zacks Research estimate cuts for upcoming quarters and fiscal years point to lower near-term earnings expectations, which can pressure the stock if investors were hoping for stronger growth.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $88.20 on Friday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The business has a 50-day simple moving average of $86.30 and a 200 day simple moving average of $84.68. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The stock has a market cap of $70.76 billion, a price-to-earnings ratio of 34.32, a PEG ratio of 4.60 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same period in the prior year, the business earned $0.91 EPS. The company’s revenue for the quarter was up 8.4% compared to the same quarter last year. On average, research analysts forecast that Colgate-Palmolive Company will post 3.83 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Monday, April 20th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 82.49%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a research note on Monday, May 4th. Jefferies Financial Group boosted their target price on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Piper Sandler reduced their target price on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. UBS Group boosted their target price on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Finally, Citigroup boosted their target price on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Twelve equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.